Keyphrases
Nanoparticles
100%
Rituximab
75%
2,4-dinitrochlorobenzene
72%
Diphenylcyclopropenone
66%
Dermatologist
66%
Clinical Diagnosis
51%
Nontuberculous Mycobacterial Infection
50%
Potential Toxicity
50%
Mutagenicity
46%
Ciprofloxacin
44%
Clinical Presentation
44%
Histopathological Examination
44%
Fluconazole
44%
Ames Assay
43%
Erythema multiforme
40%
Pemphigus Vulgaris
40%
Neoplasms
40%
Full-thickness
40%
Photoactivation
37%
Skin Care Products
36%
Esophageal Adenocarcinoma
33%
Febrile Ulceronecrotic Mucha-Habermann Disease
33%
Nasolacrimal Duct
33%
Squaric Acid
33%
Tanning Bed Use
33%
Lichenoid
33%
Nano Titanium Dioxide
33%
Dermal Effects
33%
Photochemical Stability
33%
Herpes Zoster
33%
Terazosin Hydrochloride
33%
Acute Generalized Exanthematous Pustulosis
33%
Nano-TiO2
33%
Ophthalmic Drops
33%
Transitional Cell
33%
Pemphigus Vegetans
33%
Nanosize
33%
Anatase Titanium Dioxide
33%
Secondary Syphilis
33%
Cutaneous Metastasis
33%
Syphilitic Meningomyelitis
33%
Nanotoxicology
33%
Cutaneous Reaction
33%
Cosmetic Products
33%
Biomedical Products
33%
Vitamin K
33%
Primary Syphilis
33%
Vitamin K1
33%
Acute Fatty Liver
33%
Cutaneous Adverse Drug Reactions (cADRs)
33%
Medicine and Dentistry
Infection
80%
Dermatology
76%
Rituximab
75%
Mycobacterium Avium-Intracellulare Infection
66%
Dermatological Agent
61%
Psoriasis
50%
Disease
45%
Neoplasm
40%
Alopecia Areata
40%
Injury
40%
Diabetes Mellitus
38%
Dermatosis
38%
Pemphigus vulgaris
38%
Rheumatoid Arthritis
38%
Inflammatory Arthritis
38%
Phototherapy
38%
Ciprofloxacin
38%
Esophageal Adenocarcinoma
33%
Agents Acting on the Eye
33%
Mutagenicity
33%
Diphenylcyclopropenone
33%
Vitamin D Deficiency
33%
Lichenoid
33%
Palmar Erythema
33%
Stevens-Johnson Syndrome
33%
Linagliptin
33%
AIDS-related Complex
33%
Twenty Nail Dystrophy
33%
Lymphogranuloma Venereum
33%
Mycobacterial Infection
33%
Pemphigus Vegetans
33%
Abscess
33%
Nasolacrimal Duct
33%
Vitamin D
33%
Hypovitaminosis D
33%
Disease Predisposition
33%
Phylloquinone
33%
Skin Metastasis
33%
Secondary Syphilis
33%
Carbon Monoxide Intoxication
33%
Erythroderma
33%
Tenosynovitis
33%
Skin Manifestation
33%
Blood Flow
33%
Umbilicus
33%
Meningitis
33%
Systemic Lupus Erythematosus
33%
Reticulosarcoma
33%
Liver Cirrhosis
33%
Combination Therapy
33%
